BSX paid $523M in cash to complete its acquisition of Nalu Medical, Inc.
Filing excerpt
During the first quarter of 2026, cash provided by (used for) investing activities included net cash payments of $523 million for the acquisition of Nalu Medical, Inc.
What this signalsIntegration work after a deal often opens needs for new systems and services.
sec-10qacquisitionCompletedGet every 10-Q signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/7910e5dc-5880-4232-9ab5-95fdf19a07c8 returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "7910e5dc-5880-4232-9ab5-95fdf19a07c8",
"signal_type": "sec-10q",
"signal_subtype": "acquisitionCompleted",
"detected_at": "2026-05-05T08:48:22.54+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "BSX paid $523M in cash to complete its acquisition of Nalu Medical, Inc. Post-acquisition integration activities are now underway, creating immediate needs for system consolidation, data migration, and change management services to realize deal synergies.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Net cash payment for acquisition of Nalu Medical, Inc.",
"dollar_millions": 523
},
"summary": "BSX completed acquisition of Nalu Medical for $523M in Q1 2026.",
"excerpts": "During the first quarter of 2026, cash provided by (used for) investing activities included net cash payments of $523 million for the acquisition of Nalu Medical, Inc.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000033/bsx-20260331.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Active integration needs",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/7910e5dc-5880-4232-9ab5-95fdf19a07c8 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.